We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 3

2.
Figure 2

Figure 2. From: High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis.

Kaplan-Meier survival plots. (A) All patients, and (B,C) according to tertiles of baseline levels of serum-free light chain (SFLC). Overall survival and event-free survival were inferior among patients with top-tertile SFLC baseline levels.

Frits van Rhee, et al. Blood. 2007 August 1;110(3):827-832.
3.
Figure 3

Figure 3. From: High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis.

Kaplan-Meier plots of overall survival from landmarks of SFLC reduction. (A) By day 7 of the first induction cycle, (B) before cycle 2, and (C) before transplantation. Top-tertile SFLC reductions are associated with inferior survival when considered before cycle 2 and before transplantation, unadjusted for SFLC baseline values.

Frits van Rhee, et al. Blood. 2007 August 1;110(3):827-832.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk